Like GLP-1 medications, BPC-157 is metabolized through standard peptide hydrolysis rather than CYP450 enzymes
These occurrences are more likely coincidental rather than causally related to the medication itself
doi: 10.1136/svn-2018000205 39 GgotekASkrzydlewskaE
He felt himself get out of breath more often
Kidney injury: There is a slight risk of damage to your kidneys, particularly if you have experienced gastrointestinal side effects with the medication
Although achieving surrogate histopathological endpoints is considered by regulatory agencies to likely translate to improved prognosis, robust evidence is needed to understand if GLP1 agonists reduce the risk of long-term clinical outcomes, such as liver decompensation or HCC, Axel Wester, MD, PhD, assistant professor of medicine at Karolinska Institute, and colleagues wrote